SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs informs about analyst meet

10 Jun 2021 Evaluate

Pursuant to the provisions of Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Aarti Drugs has informed that the officials of the Company will be attending the Investor Conference on 10th June 2021 with Equirus Securities. The copy of Investor Presentation March 2021 to be shared with participants has already been uploaded on stock exchanges and is also available on the website of the Company at www.aartidrugs.co.in. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. The changes may happen due to exigencies on the part of Host/ Company.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

371.05 -3.80 (-1.01%)
24-Jun-2026 14:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.65
Dr. Reddys Labs. 1336.60
Cipla 1443.35
Zydus Lifesciences 1103.00
Lupin 2375.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: